95 related articles for article (PubMed ID: 10768913)
1. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Heart; 2000 May; 83(5):577-8. PubMed ID: 10768913
[No Abstract] [Full Text] [Related]
2. Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Am J Cardiol; 2001 Jan; 87(1):107-10, A9. PubMed ID: 11137845
[TBL] [Abstract][Full Text] [Related]
3. Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project.
Lip GY; Blann AD; Farooqi IS; Zarifis J; Sagar G; Beevers DG
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):339-47. PubMed ID: 12032400
[TBL] [Abstract][Full Text] [Related]
4. Determinants of occurrence of aortic sclerosis in an aging population.
Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
7. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
8. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
9. Is it time for a new paradigm in calcific aortic valve disease?
Owens DS; Otto CM
JACC Cardiovasc Imaging; 2009 Aug; 2(8):928-30. PubMed ID: 19679279
[No Abstract] [Full Text] [Related]
10. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
Cherian P; Hankey GJ; Eikelboom JW; Thom J; Baker RI; McQuillan A; Staton J; Yi Q
Stroke; 2003 Sep; 34(9):2132-7. PubMed ID: 12907813
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
12. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
13. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces.
Ruggeri ZM
Thromb Haemost; 1995 Jul; 74(1):460-3. PubMed ID: 8578507
[TBL] [Abstract][Full Text] [Related]
14. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation.
Wilhelmi MH; Mertsching H; Wilhelmi M; Leyh R; Haverich A
J Heart Valve Dis; 2003 Jul; 12(4):520-6. PubMed ID: 12918857
[TBL] [Abstract][Full Text] [Related]
15. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
[TBL] [Abstract][Full Text] [Related]
17. An analysis of turbulence spectra in the anterior-posterior diameter in the great vessels in humans with normal and diseased heart valves.
Paulsen PK; Gormsen J; Hasenkam JM; Nygård H; Albrechtsen O
Life Support Syst; 1983; 1 Suppl 1():336-9. PubMed ID: 6336441
[No Abstract] [Full Text] [Related]
18. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
19. Systemic endothelial cell markers in primary antiphospholipid syndrome.
Williams FM; Parmar K; Hughes GR; Hunt BJ
Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
Blann AD; Choudhury A; Freestone B; Patel J; Lip GY
Int J Cardiol; 2008 Jun; 127(1):135-7. PubMed ID: 17555832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
